pharosis (Fig. 4) . A skin biopsy was taken from a papule. Hematoxylin-eosin and Periodic Acid Schiff (PAS) stains revealed amorphous, PAS-positive hyaline material in the walls of the dermal vessels, around the eccrine sweat glands, and along the dermoepidermal junction; this confirmed the diagnosis of lipoid proteinosis (Fig. 5 ).
Discussion
Lipoid proteinosis was first described by Urbach and Wiethe in 1929 under the name "hyalinosis cutis et mucosae." It is a rare, autosomal-recessive genodermatosis with around 300 cases described globally so far (5) . The condition is due to a mutation in the ECM1 gene on chromosome 1q21. ECM is a glycoprotein with three varieties-ECM1a, ECM1b, and ECM1c. ECM1 is expressed in the dermis, basal keratinocytes, endothelial cells, and developing bones and is associated with keratinocyte differentiation, basement membrane regulation, collagen composition, and growth factor binding (3) .
The mutation of the ECM1 gene leads to deposition of hyaline material in the dermis, with thickening of the skin and mucous basement membranes, blood vessels, and adnexal epithelia. Patients present with abnormal scarring and wound healing, and premature aging of the skin (3, 6) . Hoarseness is present at birth or early infancy in approximately two-thirds of patients and is due to infiltration of the larynx with hyaline material. The condition progresses with time (7) .
Lipoid proteinosis is a multisystem disease, and CNS involvement is seen in 50-75% of individuals. Infiltration of the CNS occurs predominantly in the hippocampal capillaries, with resultant wall thickening, later progressing to perivascular calcium deposition. Microscopic findings are amorphous calcifications surrounded by gliotic tissue and calcified, thickened capillary walls (8) . Neurologic manifestations range from migraine, seizure disorder, and depression to anxiety disorder. Lipoid proteinosis patients were found to have an increased incidence of mood, anxiety, and psychotic disorders (9, 10). The patients also had varying degrees of mental retardation, as well as disturbances in decision making and memory, and abnormal social interaction. This multitude of neuropsychiatric symptoms may prompt CT or MR evaluation of patients, which in symptomatic individuals can lead to a proper diagnosis.
The typical imaging finding in ipoid proteinosis is intracranial, fairly dense calcifications in the bilateral medial temporal lobes. Amygdala involvement is pathognomonic and is more prominent with a longer duration of the disease. Commonly involved sites are the amygdalae, hippocampus, the parahippocampal gyrus, and the striatum.
In CT, these calcifications appear as curvilinear or comma-shaped hyperdense lesions symmetrically in both medial temporal lobes and corpus striatum. On MRI, these lesions appear hypointense in T1 and T2 and are well brought out in T2* GRE images. In the absence of brain calcifications, the CT or MRI features of these patients are unremarkable.
Moniliform blepharosis is a pathognomonic dermatologic finding that is found in 50% of patients with lipoid proteinosis, and the diagnosis can be confirmed after dermatologic consultation. In the other 50% of patients, CT and MRI can aid in the diagnosis because of the typical sites involved in calcification.
The differential diagnosis for medial temporal lobe calcifications includes the following:
• Calcified gliomas in the amygdalohippocampal region in the pediatric population. but these are usually neither bilateral nor symmetrical.
• Raine syndrome-a very rare autosomal-recessive, sclerotic, bone dysplasia, characterized (among other findings) by intracranial calcifications. The calcifications rarely affect blood vessel walls and mainly affect the basal ganglia. There were no records of calcification in the amygdalae.
• Healed herpes encephalitis. Dystrophic temporal lobe calcifications can occur as a late sequelae of herpes encephalitis (9).
• Amygdalae, as a part of the limbic system, play a key role in mediating emotions, especially fear recognition in relation to possible danger and threat, modulation of attention, perception, learning, and emotional long-term memory (10, 11) .
• Generalised dystonias have been described in patients with striatal calcifications (2). very specific sites such as the amygdala, the hippocampus, the parahippocampal gyrus, and the corpus striatum. These locations help explain the myriad neurologic signs in these patients. CT and MRI of the brain help in identifying this pathognomonic pattern of calcification, leading to the correct diagnosis in the proper clinical setting.
Conclusion

